hypoglycemic drugs

A long-standing controversy with oral hypoglycemic drugs is that, while they lower blood glucose levels, there is little or no evidence that they add years to a patient's life. So, lower glucose levels in type 2 patients have, in effect, been little more than a controversial marker of disease. Until now.